Melola Discovery

← Melola Discovery

Journal

Formulation and Antibacterial Activity Testing of Nanoemulsion Cream from Coriander Seed Extract (Coriandrum sativum L.) in Inhibiting Protein Synthesis of Staphylococcus aureus Bacteria

Journal of Science and Technology Research for Pharmacy · Vol. 5 No. 1 (2025) · pp. 14–26

DOI
10.15294/jstrp.v5i1.26815
ISSN
2776-0685
Published
2025-07-25
Publisher
Universitas Negeri Semarang
Language
eng

Abstract

Bullous impetigo is a contagious skin infection caused by Staphylococcus aureus, characterized by the formation of fluid-filled bullae. The use of topical antibiotics for impetigo treatment has side effects, including the increased risk of bacterial resistance, leading to reduced efficacy. Natural alternatives such as coriander seeds (Coriandrum sativum L.) have the potential as antibacterial agents with fewer side effects. This study aimed to formulate and evaluate the antibacterial activity of a nanoemulsion cream containing coriander seed extract against Staphylococcus aureus. The extraction of coriander seeds was carried out using the maceration method with 96% ethanol to obtain a thick extract, followed by phytochemical screening to qualitatively identify bioactive compounds and a quantitative total flavonoid test, which resulted in a flavonoid content of 61.64 mg QE/g. The nanoemulsion was formulated using PEG 400 and VCO as the oil phase, while Tween 80, distilled water, and coriander seed extract at concentrations of 2.5%, 5%, and 7.5% were used as the aqueous phase. The nanoemulsion was then incorporated into a cream base containing stearic acid, cera alba, and white vaseline as the oil phase, and TEA, propylene glycol, methylparaben, and distilled water as the aqueous phase, heated in a water bath at 75°C. The resulting preparations were evaluated and tested for antibacterial activity using the well diffusion method. The bioactive compounds identified in coriander seed extract include alkaloids, saponins, tannins, terpenoids, and flavonoids, which exhibit antibacterial activity against Staphylococcus aureus. The antibacterial test results showed that the inhibition zones for F1 (2.5%), F2 (5%), and F3 (7.5%) were 15.00 mm, 22.00 mm, and 28.33 mm, respectively, while the positive control had an inhibition zone of 30.67 mm. The highest antibacterial activity was obtained at the F3 concentration (7.5%) with an inhibition zone diameter of 28.33 mm, classified as very strong.

Keywords

Collaboration network of the authors

31 authors · 51 co-authorship links

Hover or tap a name to highlight its co-authors. Double-click to open the author's page.

  • Institut Agama Islam Negeri Kendari
  • State University of Semarang
  • Affiliation unknown
  • Different organisations
  • Same organisation
  • Affiliation unknown
  • Thicker line = more joint articles · bigger circle = more articles
Show as table
Co-authorOrganisationJoint articles
Bertakalswa HermawatiAffiliation unknown3
Jayanti Evananda FebrianAffiliation unknown2
Yunita Dyah Puspita SantikAffiliation unknown2
Fitri IndrawatiAffiliation unknown2
Anisa FitriInstitut Agama Islam Negeri Kendari2
Arvia Dhitya MaharhaniAffiliation unknown2
Devita Uzlah SibaraniAffiliation unknown1
Sherly GusnawanAffiliation unknown1
Hermi Nur LaelaAffiliation unknown1
Arum SiwiendrayantiState University of Semarang1
Fitriana PuspitaraniAffiliation unknown1
Isnaningsih IsnaningsihAffiliation unknown1
Fitriyana FitriyanaAffiliation unknown1
Rudatin WindraswaraAffiliation unknown1
Annisa Arum Kartika DewiAffiliation unknown1
Atiya InayahAffiliation unknown1
Siti Yuliana SyafriatiAffiliation unknown1
Nila KusumawatiAffiliation unknown1
Aswi Nur SyahbaniAffiliation unknown1
Ragil AndrianiAffiliation unknown1
Isnaini Alfazcha ZukhrufAffiliation unknown1
Azizah Nur AbdillahAffiliation unknown1
Afifah Maulidia Az Zahro'Affiliation unknown1
Dela Putri WulandariAffiliation unknown1
Nanda Putri DewantiAffiliation unknown1
Siti Lailatin NasifahAffiliation unknown1
Ella Wahyu IrawanAffiliation unknown1
Erna Zuliana MuanifahAffiliation unknown1
Dwi Salsabilla PutriAffiliation unknown1

Affiliations come from OpenAlex; journal OAI-PMH metadata carries none. Authors without an OpenAlex ID are matched by name, which can merge or split people.

Metadata source: OAI-PMH (metadata jurnal) https://journal.unnes.ac.id/journals/JSTRP/oai, first harvested 5 Nov 2026, last seen 5 Nov 2026.
Original metadata (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en">Formulation and Antibacterial Activity Testing of Nanoemulsion Cream from Coriander Seed Extract (Coriandrum sativum L.) in Inhibiting Protein Synthesis of Staphylococcus aureus Bacteria</dc:title>
	<dc:creator xml:lang="en">Az Zahra, Intan Tasya</dc:creator>
	<dc:creator xml:lang="en">Sukendra, Dyah Mahendrasari</dc:creator>
	<dc:subject xml:lang="en">Antibakterial</dc:subject>
	<dc:subject xml:lang="en">Coriandrum sativum L</dc:subject>
	<dc:subject xml:lang="en">nanoemulsion cream</dc:subject>
	<dc:subject xml:lang="en">Staphylococcus aureus</dc:subject>
	<dc:description xml:lang="en">Bullous impetigo is a contagious skin infection caused by Staphylococcus aureus, characterized by the formation of fluid-filled bullae. The use of topical antibiotics for impetigo treatment has side effects, including the increased risk of bacterial resistance, leading to reduced efficacy. Natural alternatives such as coriander seeds (Coriandrum sativum L.) have the potential as antibacterial agents with fewer side effects. This study aimed to formulate and evaluate the antibacterial activity of a nanoemulsion cream containing coriander seed extract against Staphylococcus aureus. The extraction of coriander seeds was carried out using the maceration method with 96% ethanol to obtain a thick extract, followed by phytochemical screening to qualitatively identify bioactive compounds and a quantitative total flavonoid test, which resulted in a flavonoid content of 61.64 mg QE/g. The nanoemulsion was formulated using PEG 400 and VCO as the oil phase, while Tween 80, distilled water, and coriander seed extract at concentrations of 2.5%, 5%, and 7.5% were used as the aqueous phase. The nanoemulsion was then incorporated into a cream base containing stearic acid, cera alba, and white vaseline as the oil phase, and TEA, propylene glycol, methylparaben, and distilled water as the aqueous phase, heated in a water bath at 75°C. The resulting preparations were evaluated and tested for antibacterial activity using the well diffusion method. The bioactive compounds identified in coriander seed extract include alkaloids, saponins, tannins, terpenoids, and flavonoids, which exhibit antibacterial activity against Staphylococcus aureus. The antibacterial test results showed that the inhibition zones for F1 (2.5%), F2 (5%), and F3 (7.5%) were 15.00 mm, 22.00 mm, and 28.33 mm, respectively, while the positive control had an inhibition zone of 30.67 mm. The highest antibacterial activity was obtained at the F3 concentration (7.5%) with an inhibition zone diameter of 28.33 mm, classified as very strong.</dc:description>
	<dc:publisher xml:lang="en">Universitas Negeri Semarang</dc:publisher>
	<dc:date>2025-07-25</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.unnes.ac.id/journals/JSTRP/article/view/26815</dc:identifier>
	<dc:identifier>10.15294/jstrp.v5i1.26815</dc:identifier>
	<dc:source xml:lang="en">Journal of Science and Technology Research for Pharmacy; Vol. 5 No. 1 (2025): Journal of Science and Technology Research for Pharmacy; 14-26</dc:source>
	<dc:source>2776-0685</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://journal.unnes.ac.id/journals/JSTRP/article/view/26815/5146</dc:relation>
	<dc:rights xml:lang="en">Copyright (c) 2025 Journal of Science and Technology Research for Pharmacy</dc:rights>
</oai_dc:dc>